Keel Point, LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History
Keel Point, LLC
- $1.19 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
674Shares Held
111MCall Options Held
1.23MPut Options Held
1.17M-
Capital World Investors Los Angeles, CA16.5MShares$4.39 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.39 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.54 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.39 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$1.12 Billion0.19% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...